Pembrolizumab for head and neck cancer

1 Views
administrator
administrator
07/06/23

Visit http://www.ecancer.org

Dr Tanguy Seiwert (University of Chicago, Chicago, USA) presents the results of a 132-patient study that indicates that pembrolizumab immunotherapy is effective for patients with recurrent or metastatic head and neck cancer (HNC) during a press conference at ASCO 2015.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next